Published in Cerebrovasc Dis on July 04, 2014
Stroke Mechanism Evolution in Intracranial Atherosclerotic Stenosis | NCT02705599
Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res (2017) 0.81
CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. J Neurosurg (2015) 0.78
Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions. Brain Behav (2016) 0.76
DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis. Cerebrovasc Dis (2015) 0.75
Histological Characteristics of Intracranial Atherosclerosis in a Chinese Population: A Postmortem Study. Front Neurol (2017) 0.75
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57
A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol (2000) 4.29
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97
Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol (1998) 2.90
Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology (1989) 2.74
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
Arterial territories of the human brain: cerebral hemispheres. Neurology (1998) 2.47
Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology (2003) 2.34
Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry (2005) 1.81
Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke (2005) 1.81
Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol (2003) 1.77
Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke (2006) 1.76
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64
Arterial territories of human brain: brainstem and cerebellum. Neurology (1996) 1.59
Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke (2000) 1.57
Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry (2005) 1.52
Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke (2010) 1.30
Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol (2009) 1.30
Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol (2006) 1.19
Atherosclerotic disease of the middle cerebral artery. Stroke (1987) 1.18
Pathophysiological concepts of stroke in hemodynamic risk zones--do hypoperfusion and embolism interact? Nat Clin Pract Neurol (2008) 1.00
Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease. Neurology (2004) 0.92
Diffusion-weighted magnetic resonance imaging in symptomatic vertebrobasilar atherosclerosis and dissection. Arch Neurol (2005) 0.89
The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res (2011) 0.87
The relationship between neurological worsening and lesion patterns in patients with acute middle cerebral artery stenosis. Cerebrovasc Dis (2013) 0.83
Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2012) 0.82
Watershed infarcts in a multiple microembolic model of monkey. Neurosci Lett (2011) 0.80
Difference in infarct volume and patterns between cardioembolism and internal carotid artery disease: focus on the degree of cardioembolic risk and carotid stenosis. Cerebrovasc Dis (2010) 0.79
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol (2010) 4.12
Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol (2014) 3.88
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Risk assessment for ectasia after corneal refractive surgery. Ophthalmology (2007) 3.47
The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol (2010) 3.21
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
An appraisal of multivariable logistic models in the pulmonary and critical care literature. Chest (2003) 3.17
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
The resident surgeon phacoemulsification learning curve. Arch Ophthalmol (2007) 2.57
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 2.50
Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology (2011) 2.49
Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46
Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med (2003) 2.27
Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med (2002) 2.22
Long-term risk of glaucoma after congenital cataract surgery. Am J Ophthalmol (2013) 2.22
Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol (2013) 2.20
Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis (2006) 2.19
Congruency in homonymous hemianopia. Am J Ophthalmol (2007) 2.17
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16
Intravenous thrombolysis in a stroke patient taking dabigatran. J Stroke Cerebrovasc Dis (2012) 2.11
Risk stratification for the in-hospital mortality in subarachnoid hemorrhage: the HAIR score. Neurocrit Care (2014) 2.05
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology (2013) 2.00
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke (2013) 1.94
Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage. Neurology (2013) 1.90
Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke (2007) 1.81
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol (2008) 1.71
Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol (2005) 1.70
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med (2013) 1.68
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr (2007) 1.66
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63
Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys (2008) 1.63
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes (2012) 1.63
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58
Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology (2010) 1.56
Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2009) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53
Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis. Neurology (2011) 1.53
Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission. Crit Care Med (2013) 1.52
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51
Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51
Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation (2015) 1.48